• Info
  • Significant Ownership

Significant Ownership of Forbion Capital Fund IV Cooperatief U.A.

Signature - Title
/s/ V. van Houten /s/ G.J. Mulder - V. van Houten and G.J. Mulder, Directors of its Director
Location
Naarden, Netherlands
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Forbion Capital Fund IV Cooperatief U.A..

Notify me when Forbion Capital Fund IV Cooperatief U.A. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Forbion Capital Fund IV Cooperatief U.A.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NAMS NewAmsterdam Pharma Company N.V. Ordinary Shares, Nominal value 0.12 per share 8.3% $223,140,090 -$30,222,313 9,316,914 -12% ForGrowth NAP B.V. 26 Sep 2025
DYN Dyne Therapeutics, Inc. Common Stock, par value $0.0001 4.8% $60,000,055 5,400,545 ForDyne B.V. 31 Mar 2025

Schedules 13D/G Reported by Forbion Capital Fund IV Cooperatief U.A.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.